Benson Investment Management Company’s GSK GSK Stock Holding History

Benson Investment Management Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,649	Closed	-$90K	–	57
2022 Q2	$90K	Hold	1,649	–	–	0.06%	49
2022 Q1	$90K	Hold	1,649	–	–	0.05%	50
2021 Q4	$91K	Hold	1,649	–	–	0.04%	48
2021 Q3	$79K	Hold	1,649	–	–	0.04%	55
2021 Q2	$82K	Hold	1,649	–	–	0.04%	55
2021 Q1	$74K	Hold	1,649	–	–	0.04%	48
2020 Q4	$76K	Hold	1,649	–	–	0.05%	44
2020 Q3	$78K	Hold	1,649	–	–	0.05%	46
2020 Q2	$84K	Hold	1,649	–	–	0.06%	45
2020 Q1	$78K	Hold	1,649	–	–	0.06%	45
2019 Q4	$97K	Hold	1,649	–	–	0.06%	45
2019 Q3	$88K	Hold	1,649	–	–	0.06%	46
2019 Q2	$82K	Hold	1,649	–	–	0.06%	44
2019 Q1	$86K	Hold	1,649	–	–	0.07%	46
2018 Q4	$79K	Hold	1,649	–	–	0.07%	48
2018 Q3	$83K	Hold	1,649	–	–	0.06%	51
2018 Q2	$83K	Hold	1,649	–	–	0.07%	52
2018 Q1	$81K	Buy	+1,649	New	+$76.8K	0.07%	56
2017 Q4	–	Sell	-1,649	Closed	-$84K	–	66
2017 Q3	$84K	Hold	1,649	–	–	0.07%	62
2017 Q2	$89K	Hold	1,649	–	–	0.08%	61
2017 Q1	$87K	Hold	1,649	–	–	0.09%	58
2016 Q4	$79K	Buy	+1,649	New	+$81.5K	0.08%	61

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Benson Investment Management Company's GSK Position: Q3 2022 in Review

Benson Investment Management Company sold out of GSK (GSK) in Q3 2022, closing a stake of 1,649 shares — an estimated $90K sold.

Benson Investment Management Company first reported a position in GSK in Q4 2016 and held it in 22 quarters. The position peaked at $97K in Q4 2019. 743 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

Benson Investment Management Company reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
Benson Investment Management Company sold 1,649 GSK shares in Q3 2022, an estimated $90K.
Benson Investment Management Company first reported a position in GSK in Q4 2016 and held it in 22 quarters.
Benson Investment Management Company's GSK position peaked at $97K in Q4 2019.
743 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Benson Investment Management Company's 13F filing for Q3 2022, filed 20 Oct 2022.